Collectively, these results reveal that activation of the cGAS‒STING pathway facilitates kidney injury, meaning that some drugs inhibiting the pathway may be potential new therapeutic directions for preventing the progression of AKI and CKD. Here, CGAS is linked to chronic kidney disease.